PSA AFTER DEFINITIVE RADIOTHERAPY FOR CLINICALLY LOCALIZED PROSTATE CANCER
- 1 November 1993
- journal article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 20 (4) , 727-736
- https://doi.org/10.1016/s0094-0143(21)00925-3
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prostate Specific Antigen after External Beam Radiotherapy for Prostatic Cancer: FollowupJournal of Urology, 1993
- Prostate-specific antigen as a prognostic factor for prostate cancer treated by external beam radiotherapyInternational Journal of Radiation Oncology*Biology*Physics, 1992
- Prostate-specific antigen as a predictor of radiotherapy response and patterns of failure in localized prostate cancer.Journal of Clinical Oncology, 1992
- Prostate Specific Antigen in the Management of Patients with Localized Adenocarcinoma of the Prostate Treated with Primary Radiation TherapyJournal of Urology, 1991
- Prostatc specific antigen as an indicator of response to radiotherapy in prostate cancerInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Clinical use of Prostate Specific Antigen in Patients with Prostate CancerJournal of Urology, 1989
- Prostate Specific Antigen in the Diagnosis and Treatment of Adenocarcinoma of the Prostate. II. Radiation Treated PatientsJournal of Urology, 1989
- The Value of Serum Prostate Specific Antigen Determinations Before and after Radical ProstatectomyJournal of Urology, 1989
- Combined Gold Seed Implantation and External Radiotherapy for Stage B2 or C Prostate CancerJournal of Urology, 1988
- Prostatic Specific Antigen and Prostatic Acid Phosphatase in the Monitoring and Staging of Patients with Prostatic CancerJournal of Urology, 1987